Interestingly, HIPK2 inhibition can be achieved in cancer cells by tumor hypoxia or by hyperglycemia [48,53], two conditions involved in both tumor progression and in fibrosis [54,55,56,57]. Here, HIPK2 is linked to Hyperglycemia.